Download PDF
Klinische Neurophysiologie 2004; 35(4): 255-259
DOI: 10.1055/s-2004-834546
Originalia
© Georg Thieme Verlag KG Stuttgart · New York

Neuralgische Amyotrophie: Klinik, Elektrophysiologie und Therapie

Neuralgic Amyotrophy: Clinical Course, Electrophysiological Findings, TherapyP.  Young1 , G.  Kuhlenbäumer1, 2
  • 1Klinik und Poliklinik für Neurologie
  • 2Institut für Arterioskleroseforschung, Universitätsklinikum Münster, Westfälische Wilhelms-Universität Münster
Further Information

Publication History

Publication Date:
06 December 2004 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die neuralgische Amyotrophie (NA) ist eine zweiphasig verlaufende temporäre Erkrankung, die meistens den Plexus brachialis betrifft. Initial führendes Symptom ist eine akut einsetzende, vorübergehende, neuralgiforme Zervikobrachialgie, auf die temporäre Paresen und Atrophien der Schulter und/oder der Armmuskulatur folgen. In der Mehrzahl der Fälle kommt es zu einer völligen Restitution. Die elektrophysiologischen Befunde sind unspezifisch und zeichnen sich im Verlauf der Erkrankung durch Zeichen der axonalen Schädigung betroffener Nerven aus. Therapeutische Strategien bestehen in einer suffizienten Schmerztherapie zu Beginn der Erkrankung und einer intensiven Physiotherapie im weiteren Verlauf. Die Ätiologie der NA ist weit gehend unbekannt. Es werden immunologische und inflammatorische Ursachen angenommen. Aus diesem Grund kann die systemische Anwendung von Kortikoiden genutzt werden, um den Krankheitsverlauf zu modulieren. Neben der sporadischen NA gibt es eine autosomal dominante hereditäre Form, die hereditäre neuralgische Amyotrophie (HNA). Die HNA ist selten, kann aber, wenn es gelingt den genetischen und pathobiologischen Defekt aufzuklären, als Modell der sporadischen Form dienen.

Abstract

Neuralgic amyotrophy (NA) is characterized by a biphasic course affecting mainly the brachial plexus. The most striking clinical feature is the acute onset of neuralgic cervicobrachialgia followed by temporary paresis and atrophy of the shoulder and/or arm muscles. In most cases full recovery is seen. Electrophysiological findings are non-specific, and show signs of axonal damage of affected nerves. Therapeutic strategies are based on sufficient treatment of the initial pain, and in the course of the disease on physiotherapy. The ethiology of NA is unknown. Immunological and inflammatory causes are discussed. For this reason systemically administered corticosteroids may be used to modulate the course of the. The autosomal inherited form, Hereditary Neuralgic Amyotrophy (HNA) is rare. HNA may serve as a model of the sporadic NA, if the genetic and pathobiological defect will be clarified.

Key words

Neuralgic amyotrophy - hereditary neuralgic amyotrophy - brachial plexus - electrophysiology

Literatur

  • 1 Parsonage M, Turner J. Neuralgic Amyotrophy. The Shoulder-Girdle Syndrome.  Lancet. 1948;  26 973-978
    PubMedGoogle Scholar
  • 2 Vanneste J A, Bronner I M, Laman D M, Duijn H van. Distal neuralgic amyotrophy.  J Neurol. 1999;  246 399-402
    PubMedGoogle Scholar
  • 3 Stogbauer F, Young P, Kuhlenbaumer G, Jonghe P De, Timmerman V. Hereditary recurrent focal neuropathies: clinical and molecular features.  Neurology. 2000;  54 546-551
    PubMedGoogle Scholar
  • 4 Kuhlenbaumer G, Young P, Hunermund G, Ringelstein B, Stogbauer F. Clinical features and molecular genetics of hereditary peripheral neuropathies.  J Neurol. 2002;  249 1629-1650
    PubMedGoogle Scholar
  • 5 Meulemann J, Kuhlenbaumer G, Schirmacher A, Wehnert M, Jonghe P De, Vriendt E De, Young P, Airaksinen E, Pou-Serradell A, Prats J M, Ringelstein B, Stogbauer F, Broeckhoven C Van, Timmerman V. Genetic refinement of the hereditary neuralgic amyotrophy (HNA) locus at chromosome 17q25.  Eur J Hum Genet. 1999;  7 920-927
    PubMedGoogle Scholar
  • 6 Pellegrino J E, Rebbeck T R, Brown M J, Bird T D, Chance P F. Mapping of hereditary neuralgic amyotrophy (familial brachial plexus neuropathy) to distal chromosome 17q.  Neurology. 1996;  46 1128-1132
    PubMedGoogle Scholar
  • 7 Stogbauer F, Young P, Timmerman V, Spoelders P, Ringelstein E B, Broeckhoven C Van, Kurlemann G. Refinement of the hereditary neuralgic amyotrophy (HNA) locus to chromosome 17q24 - q25.  Hum Genet. 1997;  99 685-687
    PubMedGoogle Scholar
  • 8 Hunermund G, Schirmacher A, Ringelstein B, Young P, Watts G D, Meuleman J, Nelis E, Chance P F, Timmerman V, Stogbauer F, Kuhlenbaumer G. Genomic organization and mutation analysis of three candidate genes for hereditary neuralgic amyotrophy.  Muscle Nerve. 2004;  29 601-664
    PubMedGoogle Scholar
  • 9 Rubin D I. Neuralgic amyotrophy: clinical features and diagnostic evaluation.  Neurologist. 2001;  7 350-356
    PubMedGoogle Scholar
  • 10 Sundkvist T. Cytomegalovirus infection complicated by neuralgic amyotrophy.  N Engl J Med. 1983;  308 461
    PubMedGoogle Scholar
  • 11 Denning D W, Amos A, Rudge P, Cohen B J. Neuralgic amyotrophy due to parvovirus infection.  J Neurol Neurosurg Psychiatry. 1987;  50 641-642
    PubMedGoogle Scholar
  • 12 Pellas F, Olivares J P, Zandotti C, Delarque A. Neuralgic amyotrophy after parvovirus B19 infection.  Lancet. 1993;  342 503-504
    PubMedGoogle Scholar
  • 13 Puechal X, Hilliquin P, Kahan A, Menkes C J. Neuralgic amyotrophy and polyarthritis caused by parvovirus B19 infection.  Ann Rheum Dis. 1998;  57 262
    PubMedGoogle Scholar
  • 14 Kirchhoff-Moradpour A, Huzly D, Korinthenberg R, Berner R. Neuralgic amyotrophy associated with parvovirus B19 infection in a child.  Eur J Pediatr. 2001;  160 200-201
    PubMedGoogle Scholar
  • 15 Reutens D C, Dunne J W, Leather H. Neuralgic amyotrophy following recombinant DNA hepatitis B vaccination.  Muscle Nerve. 1990;  13 461
    PubMedGoogle Scholar
  • 16 Seror P. Post-partum Parsonage-Turner neuralgic amyotrophy.  J Gynecol Obstet Biol Reprod (Paris). 1999;  28 479-482
    PubMedGoogle Scholar
  • 17 Lederman R J, Wilbourn A J. Postpartum neuralgic amyotrophy.  Neurology. 1996;  47 1213-1219
    CrossrefPubMedGoogle Scholar
  • 18 Alfen N van, Schuuring J, Engelen B G van, Rotteveel J J, Gabreels F J. Idiopathic neuralgic amyotrophy in children. A distinct phenotype compared to the adult form.  Neuropediatrics. 2000;  31 328-332
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Suarez G A, Giannini C, Bosch E P, Barohn R J, Wodak J, Ebeling P, Anderson R, McKeever P E, Bromberg M B, Dyck P J. Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesis.  Neurology. 1996;  46 559-561
    CrossrefPubMedGoogle Scholar
  • 20 Cruz-Martinez A, Barrio M, Arpa J. Neuralgic amyotrophy: variable expression in 40 patients.  J Peripher Nerv Syst. 2002;  7 198-204
    CrossrefPubMedGoogle Scholar
  • 21 Byrne E. Extended neuralgic amyotrophy syndrome.  Aust N Z J Med. 1987;  17 34-348
    PubMedGoogle Scholar
  • 22 Sprung C, Fabian A. Pitfalls in computed tomography of the cervical and lumbar spine.  Neurosurg Rev. 1994;  17 19-28
    PubMedGoogle Scholar
  • 23 Refisch A, Laack W van. Neuralgic amyotrophy of the lumbar area. Case report.  Arch Orthop Trauma Surg. 1989;  108 329-332
    PubMedGoogle Scholar
  • 24 Billings R, Grahame R. Neuralgic amyotrophy with hemidiaphragmatic paralysis.  Rheumatol Rehabil. 1975;  14 260-261
    PubMedGoogle Scholar
  • 25 Mulvey D A, Aquilina R J, Elliott M W, Moxham J, Green M. Diaphragmatic dysfunction in neuralgic amyotrophy: an electrophysiologic evaluation of 16 patients presenting with dyspnea.  Am Rev Respir Dis. 1993;  147 66-71
    CrossrefPubMedGoogle Scholar
  • 26 Beydoun S R, Rodriguez R. Neuralgic amyotrophy misdiagnosed as diaphragmatic rupture.  Muscle Nerve. 1996;  19 1181-1182
    PubMedGoogle Scholar
  • 27 Hughes P D, Polkey M I, Moxham J, Green M. Long-term recovery of diaphragm strength in neuralgic amyotrophy.  Eur Respir J. 1999;  13 379-384
    CrossrefPubMedGoogle Scholar
  • 28 Lahrmann H, Grisold W, Authier F J, Zifko U A. Neuralgic amyotrophy with phrenic nerve involvement.  Muscle Nerve. 1999;  22 437-442
    CrossrefPubMedGoogle Scholar
  • 29 Nardone R, Bernhart H, Pozzera A, Taddei M, Tezzon F. Respiratory weakness in neuralgic amyotrophy: report of two cases with phrenic nerve involvement.  Neurol Sci. 2000;  21 177-181
    CrossrefPubMedGoogle Scholar
  • 30 Seror P. Isolated sensory manifestations in neuralgic amyotrophy: report of eight cases.  Muscle Nerve. 2004;  29 134-138
    PubMedGoogle Scholar
  • 31 Young P, Suter U. Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease.  Brain Res Brain Res Rev. 2001;  36 213-221
    CrossrefPubMedGoogle Scholar
  • 32 Turner J W, Parsonage M J. Neuralgic amyotrophy (paralytic brachial neuritis); with special reference to prognosis.  Lancet. 1957;  273 209-212
    PubMedGoogle Scholar
  • 33 O'Brien M D, Payan J. Neuralgic amyotrophy.  Lancet. 1980;  2 975
    PubMedGoogle Scholar
  • 34 Larson W L, Beydoun A, Albers J W, Wald J J. Collet-Sicard syndrome mimicking neuralgic amyotrophy.  Muscle Nerve. 1997;  20 1173-1177
    PubMedGoogle Scholar
  • 35 Darby M J, Wass A R, Fodden D I. Neuralgic amyotrophy presenting to an accident and emergency department.  J Accid Emerg Med. 1997;  14 41-43
    PubMedGoogle Scholar
  • 36 Berroir S, Sarazin M, Amarenco P. Vertebral artery dissection presenting as neuralgic amyotrophy.  J Neurol Neurosurg Psychiatry. 2002;  72 552-553
    PubMedGoogle Scholar
  • 37 Es H W van. MRI of the brachial plexus.  Eur Radiol. 2001;  11 325-336
    CrossrefPubMedGoogle Scholar
  • 38 Orstavik K, Skard Heier M, Young P, Stogbauer F. Brachial plexus involvement as the only expression of hereditary neuropathy with liability to pressure palsies.  Muscle Nerve. 2001;  24 1093-1096
    PubMedGoogle Scholar
  • 39 Chance P F, Alderson M K, Leppig K A, Lensch M W, Matsunami N, Smith B, Swanson P D, Odelberg S J, Disteche C M, Bird T D. DNA deletion associated with hereditary neuropathy with liability to pressure palsies.  Cell. 1993;  72 143-151
    CrossrefPubMedGoogle Scholar
  • 40 Young P, Wiebusch H, Stogbauer F, Ringelstein B, Assmann G, Funke H. A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies.  Neurology. 1997;  48 450-452
    PubMedGoogle Scholar
  • 41 Nicholson G A, Valentijn L J, Cherryson A K, Kennerson M L, Bragg T L, DeKroon R M, Ross D A, Pollard J D, McLeod J G, Bolhuis P A. et al . A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies.  Nat Genet. 1994;  6 263-266
    CrossrefPubMedGoogle Scholar
  • 42 Young P, Suter U. The causes of Charcot-Marie-Tooth disease.  Cell Mol Life Sci. 2003;  60 2547-2560
    CrossrefPubMedGoogle Scholar
  • 43 Chance P F. Molecular basis of hereditary neuropathies.  Phys Med Rehabil Clin N Am. 2001;  12 277-291
    PubMedGoogle Scholar
  • 44 Klein C J, Dyck P J, Friedenberg S M, Burns T M, Windebank A J. Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy.  J Neurol Neurosurg Psychiatry. 2002;  73 45-50
    CrossrefPubMedGoogle Scholar
  • 45 Poffenberger A L. Heredofamilial Neuritis with Brachial Predilection.  The West Virginia Medical Journal. 1968;  64 425-428
    PubMedGoogle Scholar
  • 46 Taylor R. Heredofamilial mononeuritis multiplex with brachial plexus predeliction.  Brain. 1960;  82 113-137
    PubMedGoogle Scholar
  • 47 Ardolino G, Barbieri S, Priori A. High dose intravenous immune globulin in the treatment of hereditary recurrent brachial plexus neuropathy.  J Neurol Neurosurg Psychiatry. 2003;  74 550
    CrossrefPubMedGoogle Scholar

PD Dr. Peter Young

Klinik und Poliklinik für Neurologie · Universitätsklinikum Münster

Albert-Schweitzer-Straße 33

48129 Münster

Email: young@uni-muenster.de

      >